Risk Factors Associated with the Development of Infection with Linezolid‐ and Vancomycin‐ResistantEnterococcus faecium | Zendy

Manjunath P. Pai | Zendy; Keith A. Rodvold | Zendy; Paul C. Schreckenberger | Zendy; Ronald D. Gonzales | Zendy; Jennifer M. Petrolatti | Zendy; John P. Quinn | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk Factors Associated with the Development of Infection with Linezolid‐ and Vancomycin‐ResistantEnterococcus faecium

Author(s) -

Manjunath P. Pai,

Keith A. Rodvold,

Paul C. Schreckenberger,

Ronald D. Gonzales,

Jennifer M. Petrolatti,

John P. Quinn

Publication year - 2002

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/344177

Subject(s) - linezolid , enterococcus faecium , medicine , vancomycin , enterococcus , vancomycin resistant enterococcus , daptomycin , retrospective cohort study , microbiology and biotechnology , antibiotics , staphylococcus aureus , bacteria , biology , genetics

This retrospective cohort study revealed that linezolid resistance in vancomycin-resistant Enterococcus faecium was dependent on prior linezolid exposure and duration of linezolid therapy. These strains of E. faecium were resistant to the entire class of oxazolidinones.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research